Analysts at Wedbush decreased their FY2025 EPS estimates for Voyager Therapeutics in a research note issued on Tuesday, ...

Fintel reports that on February 14, 2025, Wedbush upgraded their outlook for Welltower (NYSE:WELL) from Neutral to Outperform ...

Research analysts at Wedbush cut their Q1 2025 EPS estimates for McDonald’s in a note issued to investors on Tuesday, ...

Jensen Huang is set to meet with President Donald Trump at the White House on Friday after a tumultuous week for the ...

Tesla's ( TSLA) beat-up stock has found support on the charts, for now. After a brutal stretch this month that brought the stock's year-to-date decline to more than 30% at one point, Tesla's stock has ...

Roku stock is surging Friday after the streaming platform topped Q4 expectations and said it expects to be profitable in 2026 ...

Welltower (NYSE:WELL) was upgraded at Wedbush after the senior housing REIT "impressed with the growth outlook for 2025".

In a report released today, Alicia Reese from Wedbush maintained a Buy rating on Roku (ROKU – Research Report), with a price target of $125.00.

In a report released today, Laura Chico from Wedbush maintained a Hold rating on Ultragenyx Pharmaceutical (RARE – Research Report), with a ...